Structural enzymology of protein C
蛋白 C 的结构酶学
基本信息
- 批准号:10617783
- 负责人:
- 金额:$ 53.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:Active SitesAcuteAddressAnticoagulantsArchitectureAreaBindingBiologicalBiologyBlood Coagulation FactorBlood coagulationCoagulation ProcessComplementComplexCryoelectron MicroscopyDevelopmentDiseaseDockingEGF geneElectrostaticsEngineeringEnzymatic BiochemistryEnzyme PrecursorsEnzymesEpitopesExposure toFactor VFactor VaFactor XaFeedbackFibrinolysisFluorescence Resonance Energy TransferFunctional disorderHumanInvestigationKineticsKnowledgeLengthMapsMolecularMolecular ConformationPeptide HydrolasesPeptidesPositioning AttributeProtease DomainProtein CProtein SProteinsProthrombinRegulationResearchResearch Project GrantsResolutionShapesSideSiteSolventsSpecificityStructureTechniquesTertiary Protein StructureTestingTherapeuticThrombinThrombomodulinTimeVariantX-Ray Crystallographyactivated Protein Cbiophysical techniquescofactordata acquisitionexpectationinnovationinterestmacromoleculeparticleprotein functionprotein structureprothrombinase complexresponsescaffoldsingle moleculesuccess
项目摘要
Abstract
The proposed research project continues and expands our investigation of the interaction of thrombin with the
anticoagulant protein C responsible for a key feedback regulation of the coagulation response. The project
addresses unresolved issues in the field using an innovative structural approach and plans to fill existing gaps
in basic knowledge about protein C as a substrate of the thrombin-thrombomodulin complex and activated
protein C as an enzyme that inactivates factor Va. Unraveling the architecture of multidomain factors involved in
blood coagulation, complement and fibrinolysis remains a challenging task because of the difficulty of obtaining
high resolution structures. This limitation is even more acute when considering complexes involving these factors
and their macromolecular substrates or activators. Our approach addresses this challenge directly with cryo-EM,
the new gold standard for the structural investigation of biological macromolecules. Building on our recent
success in solving the structures of human coagulation factors V and Va, the proposed research project plans
to revolutionize the structural enzymology of protein C in a way that is relevant to other multidomain proteins and
their complexes in the blood coagulation cascade. Toward this end, we have obtained preliminary cryo-EM
structures of protein C free and bound to the thrombin-thrombomodulin complex. Once fully refined as planned
under aim 1, these unprecedented structures will unravel the mechanism of protein C activation and test the
hypothesis that thrombomodulin promotes the interaction of thrombin with protein C by offering a scaffold that
changes their conformation and alleviates electrostatic clash. In addition, we have obtained a preliminary cryo-
EM structure of activated protein C free and prepared stable particles of activated protein C bound to factor Va
and protein S for cryo-EM data acquisition. Progress from these studies will elucidate how the structure of
activated protein C compares to that of its zymogen form and will further refine the mechanism of protein C
activation. Furthermore, direct information on the epitopes of recognition of factor Va will enable a structure-
based engineering of variants of activated protein C with altered specificity for potential therapeutic applications.
摘要
拟议的研究项目继续和扩大我们的调查凝血酶的相互作用与
抗凝血蛋白C负责凝血反应的关键反馈调节。项目
使用创新的结构方法和填补现有差距的计划来解决该领域未解决的问题
在关于蛋白C作为凝血酶-血栓调节蛋白复合物的底物和活化的基础知识中,
蛋白C作为使因子Va失活的酶。揭示涉及的多领域因素的体系结构
血液凝固、补体和纤维蛋白溶解仍然是一项具有挑战性的任务,因为难以获得
高分辨率结构。当考虑到涉及这些因素的复合物时,这种局限性甚至更加严重
以及它们的大分子底物或活化剂。我们的方法直接用冷冻EM解决了这一挑战,
生物大分子结构研究的新黄金标准。基于我们最近
成功解决了人凝血因子V和Va的结构,提出了研究项目计划
以一种与其他多结构域蛋白相关的方式彻底改变蛋白C的结构酶学,
它们的复合物在血液凝固级联反应中的作用。为此,我们已经获得了初步的冷冻电镜
蛋白C的游离结构和与凝血酶-血栓调节蛋白复合物的结合。一旦按计划完全完善
根据目标1,这些前所未有的结构将揭示蛋白C激活的机制,并测试蛋白C的功能。
假设血栓调节蛋白通过提供一种支架,
改变了它们的构象并消除了静电冲突。此外,我们还获得了初步的低温-
游离活化蛋白C和制备的与因子Va结合的活化蛋白C的稳定颗粒的EM结构
和蛋白质S用于冷冻EM数据采集。这些研究的进展将阐明,
活化的蛋白C与其酶原形式相比,将进一步完善蛋白C的机制
activation.此外,关于因子Va的识别表位的直接信息将使结构-
具有改变的特异性的活化蛋白C的变体的基于工程的潜在治疗应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Enrico Di Cera其他文献
Enrico Di Cera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Enrico Di Cera', 18)}}的其他基金
Allosteric equilibria of thrombin and its precursors
凝血酶及其前体的变构平衡
- 批准号:
10429976 - 财政年份:2019
- 资助金额:
$ 53.98万 - 项目类别:
Allosteric equilibria of thrombin and its precursors
凝血酶及其前体的变构平衡
- 批准号:
9789457 - 财政年份:2019
- 资助金额:
$ 53.98万 - 项目类别:
PROTEASE SPECIFICITY AND REGULATION PROTEIN ENGINEERING
蛋白酶特异性和调控蛋白质工程
- 批准号:
8168792 - 财政年份:2010
- 资助金额:
$ 53.98万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 53.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 53.98万 - 项目类别:
Operating Grants














{{item.name}}会员




